Nathalie Brison

Leuven, VLG, Belgium

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 41 publications

Multicentric Longitudinal Performance Monitoring of Different Prenatal Cell-Free DNA Screening Technologies in Belgium.

Multicentric Longitudinal Performance Monitoring of Different Prenatal Cell-Free DNA Screening Technologies in Belgium.

Journal: Prenatal diagnosis

Published: December 26, 2025

Copy-Number Profiling and Methylation-Based Tumor Typing during Prenatal Cell-Free DNA Screening.

Copy-Number Profiling and Methylation-Based Tumor Typing during Prenatal Cell-Free DNA Screening.

Journal: Clinical chemistry

Published: July 10, 2025

Persistent Uninterpretable or Failed Prenatal Cell-Free DNA Screening Indicates a High-Risk Pregnancy and is Associated With Biological Factors Interfering With cfDNA-Analysis: A Prospective Cohort Study.

Persistent Uninterpretable or Failed Prenatal Cell-Free DNA Screening Indicates a High-Risk Pregnancy and is Associated With Biological Factors Interfering With cfDNA-Analysis: A Prospective Cohort Study.

Journal: Prenatal diagnosis

Published: January 07, 2025

Copy-number alterations in cell-free DNA can be transient or harbingers of clonal hematopoiesis.

Copy-number alterations in cell-free DNA can be transient or harbingers of clonal hematopoiesis.

Journal: NPJ precision oncology

Published: November 27, 2024

Rare Autosomal Trisomies and Adverse Perinatal Outcomes.

Rare Autosomal Trisomies and Adverse Perinatal Outcomes.

Journal: The New England journal of medicine

Published: July 10, 2024

Expanding the phenotype of copy number variations involving NR0B1 (DAX1).

Expanding the phenotype of copy number variations involving NR0B1 (DAX1).

Journal: European journal of human genetics : EJHG

Published: June 24, 2023

What helps define outcomes in persistent uninterpretable non-invasive prenatal testing: Maternal factors, fetal fraction or quality scores?

What helps define outcomes in persistent uninterpretable non-invasive prenatal testing: Maternal factors, fetal fraction or quality scores?

Journal: Prenatal diagnosis

Published: April 30, 2023

Population screening for 15q11-q13 duplications: corroboration of the difference in impact between maternally and paternally inherited alleles.

Population screening for 15q11-q13 duplications: corroboration of the difference in impact between maternally and paternally inherited alleles.

Journal: European journal of human genetics : EJHG

Published: December 21, 2022

Rare autosomal trisomies detected by non-invasive prenatal testing: an overview of current knowledge.

Rare autosomal trisomies detected by non-invasive prenatal testing: an overview of current knowledge.

Journal: European journal of human genetics : EJHG

Published: April 10, 2022

Machine learning-based detection of immune-mediated diseases from genome-wide cell-free DNA sequencing datasets.

Machine learning-based detection of immune-mediated diseases from genome-wide cell-free DNA sequencing datasets.

Journal: NPJ genomic medicine

Published: January 14, 2022

Pan-Cancer Detection and Typing by Mining Patterns in Large Genome-Wide Cell-Free DNA Sequencing Datasets.

Pan-Cancer Detection and Typing by Mining Patterns in Large Genome-Wide Cell-Free DNA Sequencing Datasets.

Journal: Clinical chemistry

Published: December 12, 2021

Non-invasive prenatal testing suggesting a maternal malignancy: What do we tell the prospective parents in Belgium?

Non-invasive prenatal testing suggesting a maternal malignancy: What do we tell the prospective parents in Belgium?

Journal: Prenatal diagnosis

Published: April 08, 2021

Showing 1-12 of 41

Last Updated: 09/26/2026